Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03DMB
|
|||
| Former ID |
DNCL003622
|
|||
| Drug Name |
Tapinarof
|
|||
| Synonyms |
GSK-2894512; GSK2894512
Click to Show/Hide
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0; ICD-9: 696] | Approved | [1] | |
| Atopic dermatitis [ICD-11: EA80; ICD-10: L20; ICD-9: 691.8, 692.9] | Phase 2 | [2] | ||
| Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 2 | [3] | ||
| Company |
Dermavant
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H18O2
|
|||
| Canonical SMILES |
CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O
|
|||
| InChI |
1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+
|
|||
| InChIKey |
ZISJNXNHJRQYJO-CMDGGOBGSA-N
|
|||
| CAS Number |
CAS 79338-84-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Aryl hydrocarbon receptor (AHR) | Target Info | Agonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 215272. | |||
| REF 2 | ClinicalTrials.gov (NCT02564042) A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis. | |||
| REF 3 | ClinicalTrials.gov (NCT01098734) Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.